Approved New Drug Applications including:

  • Dexamethasone intraocular suspension for treatment of postoperative inflammation
  • Implantable sustained release chemotherapeutic agent for prostate cancer
  • First FDA approved, intravitreal sustained release drug delivery system (antimicrobial intraocular drug delivery system)
  • Synthetic immunomodulator for the treatment of viral infectious diseases